Kanjinti 55513-0132-01
Generic: Trastuzumab-Anns
- Manufacturer
- Amgen, Inc
- Dosage Form
- Injection, Powder, Lyophilized, For Solution
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- June 11, 2019
- Listing Expires
- December 31, 2027
- Application
- BLA761073
Need to source Kanjinti? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Trastuzumab | 420 mg/20mL |
Drug Class
HER2/neu Receptor Antagonist [EPC]HER2/Neu/cerbB2 Antagonists [MoA]HER2/neu Receptor Antagonist [EPC]
Selected Package
55513-0132-01Selected1 VIAL, MULTI-DOSE in 1 CARTON (55513-132-01) / 20 mL in 1 VIAL, MULTI-DOSE
Other packages for this product(1)
1 VIAL, MULTI-DOSE in 1 CARTON (55513-132-21) / 20 mL in 1 VIAL, MULTI-DOSE